个人主页

基本信息
姓名：Ranjith Kumar Kankala
所在单位：华侨大学化工学院化工与制药工程系
华侨大学生物材料与组织工程研究所
职称：Associate Professor
电话：
电子信箱：ranjithkankala@hqu.edu.cn; ranjithkankala@yahoo.com
通讯地址：福建省厦门市集美大道668号，361021
研 究 室：化工实验大楼B415


研究领域

研究方向——构建功能化和金属浸渍纳米材料框架，构建介孔、中孔和多分隔纳米载体，用于生物医学研究。使用超临界流体技术和3D打印技术获得仿生组织/支架，用于纳米生物界面研究。
硕士生招生——化学工程，化学技术，生物化学，制药工程，分子生物学及其他相关专业。


教育背景

09/2021-04/2016 国立东华大学（台湾），纳米医学，博士；
10/2009-01/2012 印度卡卡提亚大学，药学，硕士；
08/2005-05/2009 印度卡卡提亚大学，药科，学士。


工作经历

2019年至今，华侨大学，化学工程学院，副教授/研究员。
2016年-2019年，华侨大学，化学工程学院，助理教授/研究员。
2014年-2016年，国立东华大学（台湾），助理研究员，研究项目为“无机纳米粒子中配位复合药物的封装以增强治疗效果”。
2012年-2014年，国立东华大学（台湾），助理研究员，研究项目为“用于医疗应用的双层氢氧化物纳米颗粒”。


课程教学

研究生：化工专业英语与文献阅读
本科生：文献收集与文献综述
化学工程与制药工程概论

学术兼职

美国化学会成员；
《Nature Communications》，《Materials Science and Engineering C》，《International Journal of Pharmaceutics》，《Applied Surface Science》，《RSC Open science》，《RSC Advances》，《Journal of Materials Science and Nanotechnology》，《Austin Journal of Clinical Neurology》等国际期刊审稿人。


主持或参加科研项目（课题）及人才计划项目情况（按时间倒序排序）：
台湾科技部项目，MOST 103-2113-M-259-005-MY2，配位错合物附载于无机纳米粒子以增强其治疗效率，2014/08-2016/07，80万，已结题，参加
国家自然科学基金青年项目, 黑磷量子点掺杂层状双氢氧化物复合体的构建及其光诱导促心肌分化作 用与机理研究 (**) 2019/01-2021/12, 24万 在研，主持
福建省自然科学基金项目，光引发黑磷量子点镶嵌层状双氢氧化物的促心肌分化研究（2019J01076）2019/04-2022/04, 6万，在研，主持
华侨大学中青年教师科技创新资助计划，智能纳米复合体克服多药耐药的研究，（ZQN-713）2019/04-2023/04，40万，主持

奖励荣誉
Scholastic Honorary Phi Tau Phi-2016 from "The Phi Tau Phi Scholastic Honor Society," Taiwan
Qualified Graduate Aptitude Test Examination (GATE 2009) with >90 percentile, conducted by IIT-Roorkee.
Rank in PGECET-2009 State 98 in the field of Pharmaceutical Sci.

学术成果

近五年10篇代表性期刊论文（已发表80余篇SCI论文） For more details, follow me at ResearchGate: https://www.researchgate.net/profile/Ranjith_Kumar_Kankala2
Google Scholar: https://scholar.google.com/citations?hl=en&user=YL8aDgsAAAAJ
Kankala RK et al. Nanoarchitectured Structure and Surface Biofunctionality of Mesoporous Silica Nanoparticles Advanced Materials, 2020, ** (DOI: 10.1002/adma.).
Kankala RK et al. Metal Species-Encapsulated Mesoporous Silica Nanoparticles: Current Advancements and Latest Breakthroughs, Advanced Functional Materials, 2019, **. (DOI: 10.1002/adfm.)
Kankala RK et al. Highly Porous Microcarriers for Minimally Invasive in situ Skeletal Muscle Cell Delivery, Small, 2019, **. (DOI: 10.1002/smll.) (Featured as Front cover picture)
Kankala RK* et al. Ultrasmall platinum nanoparticles enable deep tumor penetration and synergistic therapeutic abilities through free radical species-assisted catalysis to combat cancer multidrug resistance. Chemical Engineering Journal, 2020, 383:123138. (DOI: 10.1016/j.cej.2019.123138)
Kankala RK* et al. Rerouting Engineered Metal-dependent Shapes of Mesoporous Silica Nanocontainers to Biodegradable Janus-type (Sphero-ellipsoid) Nanoreactors for Chemodynamic therapy. Chemical Engineering Journal, 2019, 370:1188. (DOI: 10.1016/j.cej.2019.03.272)
Kankala RK et al. Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications. Advanced Healthcare Materials, 2017, 6: **. (DOI: 10.1002/adhm.) (Invited feature article & back cover picture)
Kankala RK et al. Fabrication of arbitrary 3D components in cardiac surgery: from macro-, micro- to nanoscale. Biofabrication, 2017, 9(3): 032002. (DOI: 10.1088/1758-5090/aa8113)
Kankala RK et al. Overcoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeutics. Journal of Materials Chemistry B, 2017, 5: 1507 (DOI: 10.1039/c6tb03146c)
Kankala RK et al. Multi-laminated metal hydroxide nanocontainers for oral-specific delivery for bioavailability improvement and treatment of inflammatory paw edema in mice. Journal of Colloid and Interface Science. 2015, 458: 217. (DOI: 10.1016/j.jcis.2015.07.044)
Kankala RK* et al. Overcoming Multidrug Resistance through the Synergistic Effects of Hierarchical pH-Sensitive, ROS-Generating Nanoreactors. ACS Biomaterials Science and Engineering, 2017, 3(10): 2431. (DOI: 10.1021/acsbiomaterials.7b00569) (Featured as Front cover picture)

论著中的章节/Book Chapters

Kankala RK, Wang SB, Chen AZ*, Zhang YS*. Chapter-2: Self-assembled Nanogels: from Particles to Scaffolds and Membranes, Title: Handbook of Nanomaterials for Cancer Theranostics (1^st Edition), Elsevier 2018. Pages 33-62, ISBN: 978-0-12-813339-2, (DOI: 10.1016/B978-0-12-813339-2.00002-5).




近五年篇代表性会议论文
[1] Kankala RK. Smart Nano-machinery for Multi-Drug Resistance. 2017中国生物材料大会. 2017年10月27-30日，中国南昌. Oral Presentation.
[2] Kankala RK. ROS-generating Nanoreactors for Cancer Theranostics. The 6th International Symposium on Surface and Interface of Biomaterials. October 16–19, 2017, Chengdu, China. Oral Presentation.
[3] Kankala RK. Surpassing Doxorubicin Resistance through Synergistic effect of Hierarchical pH-sensitive Mesoporous Organo-Inorganic Nanohybrids. 10th Textile Bioengineering and Informatics Symposium, May 15-19, 2017, Wuhan, China. Oral Presentation.
[4] Kankala RK. Targeted Antiviral-therapy for Dengue Virus-Infected Cells by Highly Efficient anti-prM Antibody Conjugated Photosensitizer Encumbered Mesoporous Silica Nanoreservoirs. 3rd International Conference on Nanotechnology in Medicine November 23-25 2015, Manchester, United Kingdom.
[5] Kankala RK. Encapsulation of Palladium-Porphyrin Photosensitizer in the Layered Double Hydroxide Nanoparticles for in vivo Photodynamic Therapy against Skin Melanoma Theragnosis. International Conference on Nanospace Materials-2015 June 22-24 2015, Taipei, Taiwan.
[6] Kankala RK. Hierarchical Liposome coated Layered Double Hydroxide Nanovehicles as potential controlled release systems for Transdermal delivery of photosensitizer. The 3rd International Conference on Advanced Materials, Energy, and Environments (ICMEE'14) July 1-3 2014, Honolulu, Hawaii, USA.
[7] Kankala RK. Controlled Drug Release from Liposome coated Layered double hydroxide Nanovehicles for the transdermal delivery of photosensitizer. 2nd USA International Conference on surfaces, coatings and Nanostructured Materials (NANOSMAT-USA) 19-22 May 2014, Rice University, Houston, Texas (USA).
[8] Kankala RK. pH-Sensitive Controlled Release Formulation of Sulfasalazine Nanovehicles with Multi-coated Eudragit copolymer for Oral Colon-Specific Drug Delivery Systems. 3^rd NANO TODAY Conference Dec 08-11 2013, Singapore.